| Cambrex is a life sciences company which is engaged in providing products and services for the development and commercialization of new and generic therapeutics. Co. primarily supplies its products and services to innovator and generic pharmaceutical companies. Co. assists companies in developing processes for the manufacture of clinical and commercial quantities. Co.'s business is primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products include active pharmaceutical ingredients, pharmaceutical intermediates and, to a lesser extent, other fine chemicals. We show 37 historical shares outstanding datapoints in our coverage of CBM's shares outstanding history.|
Understanding the changing numbers of CBM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like CBM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching CBM by allowing them to research CBM shares outstanding history
as well as any other stock in our coverage universe.